Published in

American Society for Microbiology, Journal of Clinical Microbiology, 8(60), 2022

DOI: 10.1128/jcm.00155-22

Links

Tools

Export citation

Search in Google Scholar

Diagnostic Accuracy of the Truenat MTB Plus Assay and Comparison with the Xpert MTB/RIF Assay to Detect Tuberculosis among Hospital Outpatients in Cameroon

Journal article published in 2022 by Yannick Russel Ngangue ORCID, Cyrille Mbuli ORCID, Angela Neh, Emmanuel Nshom, Armand Koudjou, Dennis Palmer, Norah Nyah Ndi, Zhi Zhen Qin ORCID, Jacob Creswell ORCID, Vincent Mbassa, Comfort Vuchas ORCID, Melissa Sander ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

The Truenat MTB Plus assay is a rapid molecular test that has been recommended by the World Health Organization since 2020 as an initial test to detect tuberculosis (TB). The WHO highlighted the need to further evaluate assay performance to inform future recommendations, including in people living with HIV and compared to the Xpert MTB/RIF assay. We conducted a prospective evaluation of the diagnostic accuracy of the Truenat assay in Cameroon, a country with a high burden of HIV/TB.